Investment Management Corp of Ontario (IMCO)’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$943K	Buy	7,159 +500	+8%	+$66.3K	0.01%	572
2025 Q4	$944K	Buy	6,659 +2,014	+43%	+$292K	0.01%	571
2025 Q3	$652K	Sell	4,645 -2,886	-38%	-$391K	0.01%	559
2025 Q2	$947K	Sell	7,531 -400	-5%	-$45.9K	0.01%	426
2025 Q1	$877K	Buy	7,931 +3,341	+73%	+$423K	0.02%	429
2024 Q4	$627K	Sell	4,590 -188	-4%	-$23.3K	0.02%	271
2024 Q3	$551K	Buy	4,778 +1,200	+34%	+$165K	0.01%	520
2024 Q2	$493K	Buy	3,578 +600	+20%	+$82.3K	0.01%	451
2024 Q1	$411K	Sell	2,978 -700	-19%	-$95.6K	0.01%	447
2023 Q4	$485K	Buy	+3,678	New	+$423K	0.01%	471
2023 Q1	–	Sell	-9,361	Closed	-$1.12M	–	202
2022 Q4	$1.12M	Buy	+9,361	New	+$1.1M	0.05%	140